258 related articles for article (PubMed ID: 27313108)
1. Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
Uzunović S; Ibrahimagić A; Hodžić D; Bedenić B
Med Glas (Zenica); 2016 Aug; 13(2):103-12. PubMed ID: 27313108
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance in Enterobacter cloacae strains with derepressed/partly derepressed/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina.
Uzunović S; Ibrahimagić A; Bedenić B
Med Glas (Zenica); 2018 Feb; 15(1):37-45. PubMed ID: 29214986
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant S. aureus (MRSA), extended-spectrum (ESBL)- and plasmid-mediated AmpC ß-lactamase -producing Gram-negative bacteria associated with skin and soft tissue infections in hospital and community settings.
Uzunović S; Bedenić B; Budimir A; Ibrahimagić A; Kamberović F; Fiolić Z; Rijnders MI; Stobberingh EE
Med Glas (Zenica); 2015 Aug; 12(2):157-68. PubMed ID: 26276654
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterisation of extended-spectrum and plasmid-mediated AmpC β-lactamase produced by
Fetahagić M; Ibrahimagić A; Uzunović S; Beader N; Elveđi-Gašparović V; Luxner J; Gladan M; Bedenić B
Arh Hig Rada Toksikol; 2021 Dec; 72(4):305-314. PubMed ID: 34985844
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
Khan MK; Thukral SS; Gaind R
Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
[TBL] [Abstract][Full Text] [Related]
9. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
[TBL] [Abstract][Full Text] [Related]
10. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
11. Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.
Uzunović S; Bedenić B; Budimir A; Kamberović F; Ibrahimagić A; Delić-Bikić S; Sivec S; Meštrović T; Varda Brkić D; Rijnders MI; Stobberingh EE
Wien Klin Wochenschr; 2014 Dec; 126(23-24):747-56. PubMed ID: 25193483
[TBL] [Abstract][Full Text] [Related]
12. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of TEM, SHV and CTX-M β Lactamases in Clinical Isolates of Proteus Species in a Tertiary Care Center.
Caubey M; Suchitra M S
Infect Disord Drug Targets; 2018; 18(1):68-71. PubMed ID: 28443500
[TBL] [Abstract][Full Text] [Related]
15. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
18. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
Aragón LM; Mirelis B; Miró E; Mata C; Gómez L; Rivera A; Coll P; Navarro F
J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
[TBL] [Abstract][Full Text] [Related]
19. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
El Aila NA; Al Laham NA; Ayesh BM
BMC Infect Dis; 2023 Feb; 23(1):99. PubMed ID: 36803466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
